Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Emmaus Life Sciences Inc (EMMA)
OTHER OTC:EMMA
RESEARCH TOOLSreports
Emmaus Life Sciences (EMMA) Stock Price & Analysis
85 Followers
EMMA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.05 - $0.28
Previous Close$0.07
Volume1.49K
Average Volume (3M)13.10K
Market Cap
$4.55M
Enterprise Value$21.09M
Total Cash (Recent Filing)$2.55M
Total Debt (Recent Filing)$19.09M
Price to Earnings (P/E)―
Beta1.48
Next Earnings
Aug 12, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding53,637,554
10 Day Avg. Volume16,345
30 Day Avg. Volume13,101
Standard Deviation0.32
R-Squared0.07
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)-0.14
Price to Sales (P/S)0.27
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio2.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.71
Enterprise Value/Gross Profit0.75
Enterprise Value/Ebitda3.96
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Emmaus Life Sciences News
Ownership Overview
39.23% Insiders
0.00% Mutual Funds
0.09% Other Institutional Investors
60.68% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
EMMA FAQ
What was Emmaus Life Sciences Inc’s price range in the past 12 months?
Emmaus Life Sciences Inc lowest stock price was $0.05 and its highest was $0.28 in the past 12 months.
What is Emmaus Life Sciences Inc’s market cap?
Currently, no data Available
When is Emmaus Life Sciences Inc’s upcoming earnings report date?
Emmaus Life Sciences Inc’s upcoming earnings report date is Aug 12, 2024 which is in 16 days.
How were Emmaus Life Sciences Inc’s earnings last quarter?
Currently, no data Available
Is Emmaus Life Sciences Inc overvalued?
According to Wall Street analysts Emmaus Life Sciences Inc’s price is currently Overvalued.
Does Emmaus Life Sciences Inc pay dividends?
Emmaus Life Sciences Inc does not currently pay dividends.
What is Emmaus Life Sciences Inc’s EPS estimate?
Emmaus Life Sciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Emmaus Life Sciences Inc have?
Emmaus Life Sciences Inc has 63,865,570 shares outstanding.
What happened to Emmaus Life Sciences Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Emmaus Life Sciences Inc?
Among the largest hedge funds holding Emmaus Life Sciences Inc’s share is Gibson Capital, Llc. It holds Emmaus Life Sciences Inc’s shares valued at N/A.
---
Emmaus Life Sciences Stock Smart Score
Company Description
Emmaus Life Sciences Inc
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company. It engages in the discovery, development, marketing and sale of innovative treatments and therapies, including those in the rare and orphan disease categories. The company is headquartered in Torrance, CA.
---
Technical Analysis
---